Drug Profile
Interferon alpha-2a biosimilar - Elea
Alternative Names: r-hu-IFNa2 - EleaLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Elea
- Class Antineoplastics; Antivirals; Interferons
- Mechanism of Action Interferon alfa 2a stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cancer; Neurological disorders; Viral infections